// App-Quantinova.ai

1223 : NG-796A: A T-SIGn vector designed to reprogram the tumor microenvironment and drive anti-tumor immunity

Researchers

Presenter

  • Manuela Zonca

Principal Investigators

  • Katy West

  • Carla Cerqueira

  • Alice Muntzer

  • Rochelle Lear

  • Samuel Hardy

  • Darren Plumb

  • Maria Stella Sasso

  • Eva Vainiute

  • Tae Hyun Jang

  • Samantha Bucktrout

  • Brian Champion

Medical Centers

  • PsOxus Therapeutics Ltd, Abingdon, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Natural Killer cells

Drug/Treatment

  • enadenotucirev

  • Interleukin

  • IL-12

  • IL-15

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved